Franz P W. Radner, et.al., Growth retardation, impaired triacylglycerol catabolism, hepatic steatosis, and lethal skin barrier defect in mice lacking comparative gene identification-58 (CGI-58)., The Journal of biological chemistry, 2010, 285

http://rdf.ncbi.nlm.nih.gov/pubmed/20023287

Franz P W. Radner, et.al., Growth retardation, impaired triacylglycerol catabolism, hepatic steatosis, and lethal skin barrier defect in mice lacking comparative gene identification-58 (CGI-58)., The Journal of biological chemistry, 2010, 285

pubmed

allele

http://purl.org/net/cito/citesAsAuthority

• Abhd5<tm1Rze>
  http://metadb.riken.jp/db/mgi_rdf/MGI:5502402
• Abhd5<tm1.1Rze>
  http://metadb.riken.jp/db/mgi_rdf/MGI:4456205

class

http://purl.org/net/cito/citesAsAuthority

• Abhd5<tm1Rze>
  http://metadb.riken.jp/db/mgi_rdf/MGI:5502402
• Abhd5<tm1.1Rze>
  http://metadb.riken.jp/db/mgi_rdf/MGI:4456205

表現型アノテーション

http://purl.org/net/cito/citesAsAuthority

• decreased body length_Abhd5<tm1.1Rze>/Abhd5<tm1.1Rze>
  http://metadb.riken.jp/0001258I129P2OlaHsdC57BL6Abhd5tm11RzeAbhd5tm11RzeAbhd5tm11Rze
• decreased fatty acid level_Abhd5<tm1.1Rze>/Abhd5<tm1.1Rze>
  http://metadb.riken.jp/0005282I129P2OlaHsdC57BL6Abhd5tm11RzeAbhd5tm11RzeAbhd5tm11Rze
• decreased triglyceride lipase activity_Abhd5<tm1.1Rze>/Abhd5<tm1.1Rze>
  http://metadb.riken.jp/0011582I129P2OlaHsdC57BL6Abhd5tm11RzeAbhd5tm11RzeAbhd5tm11Rze
• abnormal lipid homeostasis_Abhd5<tm1.1Rze>/Abhd5<tm1.1Rze>
  http://metadb.riken.jp/0002118I129P2OlaHsdC57BL6Abhd5tm11RzeAbhd5tm11RzeAbhd5tm11Rze
• increased triglyceride level_Pnpla2<tm1Rze>/Pnpla2<tm1Rze>
  http://metadb.riken.jp/0005317I129P2OlaHsdPnpla2tm1RzePnpla2tm1RzePnpla2tm1Rze
• hepatic steatosis_Abhd5<tm1.1Rze>/Abhd5<tm1.1Rze>
  http://metadb.riken.jp/0002628I129P2OlaHsdC57BL6Abhd5tm11RzeAbhd5tm11RzeAbhd5tm11Rze
• abnormal lipid homeostasis_Pnpla2<tm1Rze>/Pnpla2<tm1Rze>
  http://metadb.riken.jp/0002118I129P2OlaHsdPnpla2tm1RzePnpla2tm1RzePnpla2tm1Rze
• impaired lipolysis_Abhd5<tm1.1Rze>/Abhd5<tm1.1Rze>
  http://metadb.riken.jp/0008033I129P2OlaHsdC57BL6Abhd5tm11RzeAbhd5tm11RzeAbhd5tm11Rze
• abnormal enzyme/coenzyme activity_Pnpla2<tm1Rze>/Pnpla2<tm1Rze>
  http://metadb.riken.jp/0005584I129P2OlaHsdPnpla2tm1RzePnpla2tm1RzePnpla2tm1Rze
• increased triglyceride level_Abhd5<tm1.1Rze>/Abhd5<tm1.1Rze>
  http://metadb.riken.jp/0005317I129P2OlaHsdC57BL6Abhd5tm11RzeAbhd5tm11RzeAbhd5tm11Rze
• abnormal keratinocyte differentiation_Abhd5<tm1.1Rze>/Abhd5<tm1.1Rze>
  http://metadb.riken.jp/0002656I129P2OlaHsdC57BL6Abhd5tm11RzeAbhd5tm11RzeAbhd5tm11Rze
• increased liver triglyceride level_Abhd5<tm1.1Rze>/Abhd5<tm1.1Rze>
  http://metadb.riken.jp/0009355I129P2OlaHsdC57BL6Abhd5tm11RzeAbhd5tm11RzeAbhd5tm11Rze
• abnormal lipid level_Abhd5<tm1.1Rze>/Abhd5<tm1.1Rze>
  http://metadb.riken.jp/0001547I129P2OlaHsdC57BL6Abhd5tm11RzeAbhd5tm11RzeAbhd5tm11Rze
• abnormal skin physiology_Abhd5<tm1.1Rze>/Abhd5<tm1.1Rze>
  http://metadb.riken.jp/0005501I129P2OlaHsdC57BL6Abhd5tm11RzeAbhd5tm11RzeAbhd5tm11Rze
• decreased birth body size_Abhd5<tm1.1Rze>/Abhd5<tm1.1Rze>
  http://metadb.riken.jp/0009703I129P2OlaHsdC57BL6Abhd5tm11RzeAbhd5tm11RzeAbhd5tm11Rze
• abnormal skin development_Abhd5<tm1.1Rze>/Abhd5<tm1.1Rze>
  http://metadb.riken.jp/0003941I129P2OlaHsdC57BL6Abhd5tm11RzeAbhd5tm11RzeAbhd5tm11Rze
• impaired skin barrier function_Abhd5<tm1.1Rze>/Abhd5<tm1.1Rze>
  http://metadb.riken.jp/0002796I129P2OlaHsdC57BL6Abhd5tm11RzeAbhd5tm11RzeAbhd5tm11Rze
• decreased circulating glucose level_Abhd5<tm1.1Rze>/Abhd5<tm1.1Rze>
  http://metadb.riken.jp/0005560I129P2OlaHsdC57BL6Abhd5tm11RzeAbhd5tm11RzeAbhd5tm11Rze
• decreased birth weight_Abhd5<tm1.1Rze>/Abhd5<tm1.1Rze>
  http://metadb.riken.jp/0009674I129P2OlaHsdC57BL6Abhd5tm11RzeAbhd5tm11RzeAbhd5tm11Rze
• epidermis stratum spinosum hyperplasia_Abhd5<tm1.1Rze>/Abhd5<tm1.1Rze>
  http://metadb.riken.jp/0009611I129P2OlaHsdC57BL6Abhd5tm11RzeAbhd5tm11RzeAbhd5tm11Rze
• abnormal granulocyte morphology_Abhd5<tm1.1Rze>/Abhd5<tm1.1Rze>
  http://metadb.riken.jp/0002441I129P2OlaHsdC57BL6Abhd5tm11RzeAbhd5tm11RzeAbhd5tm11Rze
• neonatal lethality_Abhd5<tm1.1Rze>/Abhd5<tm1.1Rze>
  http://metadb.riken.jp/0002058I129P2OlaHsdC57BL6Abhd5tm11RzeAbhd5tm11RzeAbhd5tm11Rze
• decreased circulating triglyceride level_Abhd5<tm1.1Rze>/Abhd5<tm1.1Rze>
  http://metadb.riken.jp/0002644I129P2OlaHsdC57BL6Abhd5tm11RzeAbhd5tm11RzeAbhd5tm11Rze
• impaired lipolysis_Pnpla2<tm1Rze>/Pnpla2<tm1Rze>
  http://metadb.riken.jp/0008033I129P2OlaHsdPnpla2tm1RzePnpla2tm1RzePnpla2tm1Rze
• increased liver triglyceride level_Pnpla2<tm1Rze>/Pnpla2<tm1Rze>
  http://metadb.riken.jp/0009355I129P2OlaHsdPnpla2tm1RzePnpla2tm1RzePnpla2tm1Rze
• hyperkeratosis_Abhd5<tm1.1Rze>/Abhd5<tm1.1Rze>
  http://metadb.riken.jp/0001242I129P2OlaHsdC57BL6Abhd5tm11RzeAbhd5tm11RzeAbhd5tm11Rze

トランスクリプトームデータ

http://rdf.ncbi.nlm.nih.gov/pubmed/

• CD16003
  http://metadb.riken.jp/db/BrainTx/TranscriptomeData/CD16003